I have been trying to figure out what “functional health” actually means for about a month, and the first thing I noticed is that the people selling it cannot agree on the term. The same business model gets called “functional medicine,” “functional health,” “root-cause medicine,” “integrative medicine,” and “personalized medicine” by practitioners who all want […]
I have an avocado oil spray bottle. I do not know what tallow is. A 50-year-old dude reads the actual research on seed oils, dairy, and the latest dietary advice cycle — and reports what the evidence says you should put in your frying pan.
Lilly’s retatrutide just delivered bariatric-equivalent weight loss in Phase 3. The numbers, why the low dose is the real story, and the gray-market reality that got there first.
I was diagnosed with anxiety in 2021, hit 373 lbs in 2024, and started TRT in 2025. The full story, the numbers, and what the discourse misses.
Your cholesterol panel at 50, decoded. The six numbers, the new 2026 guideline targets, the coronary calcium scan, and what the drugs actually do.
I am at goal weight on Zepbound. SURMOUNT-MAINTAIN is the trial I have been waiting for. Here is what holding the line at a lower dose actually looks like.
A study of 479,000 adults found cyclists had 22% lower Alzheimer’s risk, 40% lower young-onset dementia risk, and measurably larger hippocampi than nonactive controls. Here’s what the data actually shows, the APOE caveat the headlines missed, and the negative RCT you should hold next to it.
In May 2026, three major papers landed on Lp(a) — the genetic cholesterol marker that 1 in 5 adults carry at risk levels and almost nobody gets tested for. Here’s what the new evidence says, what to do if your number is high, and the aspirin advice you should stop following.
I knew statins worked. I did not know how strange the origin story was. How statins started with mold Get the next one in your inbox I write about longevity, training, and preventive health weekly — without the guru worship. Free, no spam, unsubscribe whenever. The first statin came from Akira Endo, a Japanese biochemist
If you have Medicare and your doctor has been telling you about a new daily pill for weight loss, this post is for you. Foundayo is real, it’s FDA-approved, and starting July 1, 2026, it’s covered for $50 a month under Medicare’s GLP-1 Bridge program for eligible beneficiaries. This is genuinely new. Foundayo got FDA
